Showing results 2 to 2 of 2
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade–resistant Melanoma for Anti-PD-L1 Rechallenge Journal:Cancer Research Communications | 2022 |